Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4071131
Max Phase: Preclinical
Molecular Formula: C42H28N6O2S2
Molecular Weight: 712.86
Molecule Type: Small molecule
Associated Items:
ID: ALA4071131
Max Phase: Preclinical
Molecular Formula: C42H28N6O2S2
Molecular Weight: 712.86
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N#Cc1c(-c2ccc(-c3ccccc3)cc2)nc(SCc2ccc(CSc3nc(-c4ccc(-c5ccccc5)cc4)c(C#N)c(=O)[nH]3)cc2)[nH]c1=O
Standard InChI: InChI=1S/C42H28N6O2S2/c43-23-35-37(33-19-15-31(16-20-33)29-7-3-1-4-8-29)45-41(47-39(35)49)51-25-27-11-13-28(14-12-27)26-52-42-46-38(36(24-44)40(50)48-42)34-21-17-32(18-22-34)30-9-5-2-6-10-30/h1-22H,25-26H2,(H,45,47,49)(H,46,48,50)
Standard InChI Key: JVBYKYMXDQKSTA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 712.86 | Molecular Weight (Monoisotopic): 712.1715 | AlogP: 8.85 | #Rotatable Bonds: 10 |
Polar Surface Area: 139.08 | Molecular Species: ACID | HBA: 8 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 6.50 | CX Basic pKa: | CX LogP: 8.51 | CX LogD: 7.44 |
Aromatic Rings: 7 | Heavy Atoms: 52 | QED Weighted: 0.11 | Np Likeness Score: -0.80 |
1. Cui P, Li X, Zhu M, Wang B, Liu J, Chen H.. (2017) Design, synthesis and antimicrobial activities of thiouracil derivatives containing triazolo-thiadiazole as SecA inhibitors., 127 [PMID:28039774] [10.1016/j.ejmech.2016.12.053] |
2. Cui P, Li X, Zhu M, Wang B, Liu J, Chen H.. (2017) Design, synthesis and antibacterial activities of thiouracil derivatives containing acyl thiourea as SecA inhibitors., 27 (10): [PMID:28041832] [10.1016/j.bmcl.2016.11.060] |
Source(1):